Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution

Cancer

Volumn 115, Issue 13, 2009, Pages 2988-2998

  Palmerini, Emanuela ^a   Staals, Eric L ^a   Alberghini, Marco ^a   Zanella, Licciana ^a   Ferrari, Cristina ^a   Benassi, Maria Serena ^a   Picci, Piero ^a   Mercuri, Mario ^a   Bacci, Gaetano ^a   Ferrari, Sefano ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Chemotherapy; Prognostic factors; Radiotherapy; Soft tissue sarcoma; Synovial sarcoma

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CHILD; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SYNOVIAL SARCOMA; TREATMENT OUTCOME; TRUNK;

ADOLESCENT; ADULT; AGED; ARM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, SYNOVIAL; SURVIVAL RATE;

EID: 67649600358     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24370     Document Type: Article

References (31)

1. Brennan MF, Singer S, Maki RG, O'Sullivan B. Soft tissue sarcoma. In: DeVita VT, Hellmann S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1741-1794.
2. Eilber FC, Dry SM. Diagnosis and management of synovial sarcoma. J Surg Oncol. 2008;97:314-320. (Pubitemid 351358579)
3. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. Lyon, France: IARC Press; 2002.
4. Kawai A, Woodruff J, Healey JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998;338:153-160. (Pubitemid 28041862)
5. Panagopoulos I, Mertens F, Isaksson M, et al. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer. 2001;31:362-372. (Pubitemid 32622713)
6. Singer S, Baldini EH, Demetri GD, et al. Synovial sarcoma: prognostic significance of tumor size, margin of resection and mitotic activity for survival. J Clin Oncol. 1996;14:1201-1208. (Pubitemid 26105527)
7. Lewis JJ, Antonescu CR, Leung DHY, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18:2087-2094. (Pubitemid 30324362)
8. Spillane AJ, A'Hern R, Judson IR, et al. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol. 2000;18:3794-3803. (Pubitemid 30846225)
9. Trassard M, Le Doussal V, Hacene K, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001;19:525-534. (Pubitemid 32112867)
10. Guillou L, Benhattar J, Bonichon F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22:4040-4050. (Pubitemid 41185173)
11. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004;101:627-634. (Pubitemid 38970615)
12. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62:135-140. (Pubitemid 34073997)
13. Rosen G, Forscher C, Lowenbraun S, et al. Synovial sarcoma: uniform response of metastases to high dose ifosfamide. Cancer. 1994;73:2506-2511. (Pubitemid 24155525)
14. Karavasilis V, Seddon BM, Ashley S, et al. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Cancer.112:1585-1591.
15. Eilber FC, Brennan MF, Eilber FR, et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg. 2007;246:105-113. (Pubitemid 47012214)
16. Brodowicz T, Schwameis E, Widder J, et al. Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial. Sarcoma. 2000;4:151-160. (Pubitemid 32055721)
17. Gortzak E, Azzarelli A, Buesa J, et al. A randomized phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer. 2001;37:1096-1103.
18. Frustaci S, Gherlinzoni F, DePaoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcoma of the extremity and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19:1238-1247. (Pubitemid 32202526)
19. Pisters PW, O'Sullivan B, Maki RG.Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol. 2007;25:1003-1008. (Pubitemid 350002867)
20. Enneking WF, Spanier SS, Goodman MA.Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg. 1980;62-A:1027-1030.
21. Hasegawa T, Yamamoto S, Yokoyama R, et al. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer. 2002;95:843-851. (Pubitemid 34839677)
22. Okcu MF, Munsell M, Treuner J, et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. J Clin Oncol. 2003;21:1602-1611. (Pubitemid 46594115)
23. Spurrell EL, Fisher C, Thomas JM, et al. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol. 2005;16:437-444. (Pubitemid 40458321)
24. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituti Ortopedici Rizzoli. J Clin Oncol. 2000;18:4-11. (Pubitemid 30036330)
25. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol. 2000;18:3108-3114. (Pubitemid 30677091)
26. Lewis JJ, Leung D, Heslin M, et al. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997;15:646-652. (Pubitemid 27074234)
27. Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237:218-226. (Pubitemid 38173249)
28. Casali PG, Jost L, Sleijfer S, et al. ESMO Guidelines Working Group. Soft tissue sarcomas: ESMO clinical recommendations. Ann Oncol. 2008;19(suppl 2):ii89-ii93.
29. Kampe CE, Rosen G, Eilber F, et al. A study of intensive chemotherapy in 14 patients with localized disease. Cancer. 1993;72:2161-2169. (Pubitemid 23280141)
30. Bacci G, Forni C, Longhi A, et al. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol. 2007;96:118-123. (Pubitemid 47264814)
31. van Geel AN, Pastorino U, Jauch KW, et al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. 1996;77:675-682. (Pubitemid 26055392)